Search results
Waste Management, Inc. (NYSE:WM) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 19 hours agoB. Riley Wealth Advisors Inc. reduced its holdings in shares of Waste Management, Inc. (NYSE:WM –...
Brown Shipley& Co Ltd Has $3.62 Million Stake in Waste Management, Inc. (NYSE:WM)
ETF DAILY NEWS· 2 days agoBrown Shipley& Co Ltd raised its stake in shares of Waste Management, Inc. (NYSE:WM – Free Report)...
Why Waste Management (WM) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoWaste Management (WM) Headquartered in Houston, Texas, Waste Management Inc. is a leading provider...
Reasons to Retain Waste Management (WM) in Your Portfolio Now
Zacks via Yahoo Finance· 7 days agoWaste Management’s WM stock has had an impressive run over the past year. Shares have gained 24.7%...
Wm Morrison Supermarkets (OTCMKTS:MRWSY) Stock Price Passes Above Two Hundred Day Moving Average of...
ETF DAILY NEWS· 3 days agoWm Morrison Supermarkets PLC (OTCMKTS:MRWSY – Get Free Report)’s stock price passed above its two...
Waste Management (WM) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 day agoIn the latest market close, Waste Management (WM) reached $206.38, with a +1.35% movement compared...
Bill Gates Earns Over $1.3 Million Per Day In Dividend Income - Here Are The 3 Stocks Paying Him The...
Benzinga via Yahoo Finance· 6 days agoBill Gates, the 9th richest person in the world with an estimated net worth of $132.2 billion, has...
Pilot project resumes toxic waste removal at AltEn site
1011 News· 34 minutes agoOut in Saunders County, an abandoned ethanol plant sits on the outskirts of a small village with a...
Chestnut Ridge Landfill traffic temporarily rerouted
Gannett via AOL· 1 day agoThe repaving project will require anyone using the landfill to loop all the way around the landfill and exit at the bottom of Fleenor Mill Road. The loop around the landfill is a gravel and ...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks· 23 hours agoFree Report) reported updated results from a cohort of an ongoing phase I/II study evaluating its lead clinical candidate MB-106 in patients with Waldenstrom macroglobulinemia (WM< ...